All Medical Microbiology articles – Page 5
-
NewsThe future of phage therapy will be decided by more than science alone
As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.
-
NewsPhase 1 clinical trial set to begin on first leishmaniasis vaccine
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months. The live vaccine, found to be safe in animals, is expected to be tested in humans later this year.
-
NewsNew study identifies key warning signs for infection after ankle fracture surgery in older patients
A new study of which patients are most at risk of a fracture-related infection post ankle surgery finds that low protein levels in the blood is the single strongest patient-related risk factor, making infection nearly 18 times more likely. Chronic alcohol abuse and failure to follow post-operative instructions each raise the risk more than fivefold.
-
NewsBehind the diagnosis: How laboratory testing guided a complex histoplasmosis case
A diagnosis of histoplasmosis forced a teenager with juvenile arthritis onto an uncertain path, one defined by months of treatment, recovery, and a long-term course of antifungal therapy expected to last up to three years. Histoplasma capsulatum, a dimorphic fungus that causes histoplasmosis, found its way into her lungs.
-
NewsPost-discharge antibiotics may offer limited benefit after pediatric appendicitis
Acute appendicitis is one of the most common surgical emergencies among children, and complicated acute appendicitis (CAA), including perforated or gangrenous disease, carries a higher risk of infection and longer hospitalization. While intravenous antibiotics during hospitalization are standard practice, the role of oral home antibiotics (OHA) after discharge remains controversial. ...
-
NewsPrecigen presents new long-term durability data for PAPZIMEOS, recently granted seven-year market exclusivity
Precigen, Inc. has announced updated long-term follow-up data from the pivotal study of PAPZIMEOS™ (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
-
CareersA week in the life of a Parvovirus researcher
Alejandro Fernández Llorente works as a predoctoral researcher at Centro de Biología Molecular Severo Ochoa (CBM-CSIC), a prestigious biomedical research centre located in Madrid, Spain.
-
NewsSkin-to-skin care may save newborn lives
Kangaroo mother care, first introduced as an alternative to insufficient incubator care, combines skin-to-skin contact, exclusive breastfeeding, early discharge, and follow-up support. A new review case makes the case for treating iKMC not as an optional add-on, but as a core part of neonatal care for eligible preterm and low-birth-weight infants.
-
NewsLong Covid burden continues to grow, doubling current surveillance estimates, multi-hospital study shows
Investigators using a novel AI algorithm to comb through medical records of patients with COVID-19 in U.S. hospitals, found around one in six developed long COVID. These rates are twofold higher than current estimates.
-
NewsStudies point to new way to fight potentially deadly Valley Fever
To better understand why Valley Fever spreads in some individuals, researchers found that patients with severe illness had an abnormal immune response. In some cases, the immune system was overactive; in other cases it was underactive.
-
NewsBrazilian medical students increase vaccine confidence
Vaccination coverage in Brazil has declined in recent years. Medical students at the University of Pernambuco designed and delivered a low-cost, two-hour educational intervention for 25 parents and caregivers waiting for routine appointments at a Family Health Unit in Recife.
-
NewsAutomated EHR alert improved hepatitis B monitoring rates at a primary care clinic
In May 2024, an urban safety-net primary care clinic noted the appearance of a new “care gap” alert in their Epic electronic health record (EHR) system that flagged patients with hepatitis B who were overdue for one blood test, the hepatitis B DNA test.
-
NewsICU pneumonia has mortality rates of 37% to nearly 60% in middle-income countries. In high-income countries, rates are16% to 26%
A scientific review evaluated outcomes of adults with community-acquired pneumonia (CAP) admitted to intensive care units (ICUs) in middle-income countries. In contrast to high-income countries, where mortality ranges from 16% to 26%, the study found significantly higher rates in the countries analyzed.
-
NewsNASCAR star’s death shows how sepsis can kill anyone if not caught
Kyle Busch won more races than any driver in NASCAR history. But his own race ended far too soon, cut short by sepsis at the age of 41 after a case of pneumonia.
-
NewsPegylated interferon-based treatment improves response rates in immune-tolerant patients with chronic hepatitis B
A new study aimed to investigate the efficacy and predictive factors of a pegylated interferon (Peg-IFN)-based treatment strategy in IT patients with chronic HBV infection.
-
NewsEstablishing a regulatory framework for phage therapy in China
A new study summarizes the current regulatory frameworks for phage therapy in Western countries and China, and proposes a pathway for establishing a regulatory framework that enables safe and effective clinical application of phage therapy in China.
-
NewsWhy babies are dying and how we can stop it
A study has identified that the vast majority of neonatal deaths caused by infections in South Africa and other low-and-middle-income countries could be prevented through improved clinical care and targeted medical interventions.
-
NewsResearchers find increased bacteria infection in patients with chronic lung disease
A new study has found that people with bronchiectasis and chronic sinus disease were more likely to have mucus samples that tested positive for Pseudomonas aeruginosa. It suggests that doctors caring for patients with bronchiectasis may need to pay closer attention to sinus disease and bacterial testing.
-
NewsEurope advances genomic surveillance of CCRE with landmark multi-country study
New survey results provide the most comprehensive genomic picture to date of carbapenem- and/or colistin-resistant Enterobacterales (CCRE) across hospitals in Europe.
-
NewsBronchiectasis and NTM Care Center Network expands to 62 centers
The Bronchiectasis and NTM Association has accepted one new Care Center and three new Clinical Associate Center sites into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 62 centers across the United States.